ISELIN, NJ. — Nascent Health Sciences, LLC, received a “no questions” letter from the US Food and Drug Administration in response to its Generally Recognized as Safe notice for its SoPure steviol glycosides.
Following the FDA’s previously issued “no questions” letter for Nascent’s SoPure Reb A ingredient, the latest designation expands the confirmation to include the complete portfolio of SoPure steviol glycosides extracted and purified from the stevia leaf.
“This provides our manufacturing customers with confidence knowing that their stevia supply is not only grown naturally and sourced sustainably but is also safe and backed by the most stringent regulatory approvals,” said Hank Wang, technical director of Nascent Health Sciences.
Commercial stevia products in the SoPure range have been incorporated in formulations for a wide range of products, including beverages, baked foods, sauces and condiments, tabletop sweeteners, confectionery products, dairy products and personal care products.